Literature DB >> 29550258

Live bacterial vaccine vector and delivery strategies of heterologous antigen: A review.

Chengchao Ding1, Junfei Ma1, Qingli Dong1, Qing Liu2.   

Abstract

Live bacteria, including attenuated bacteria and probiotics, can be engineered to deliver target antigen to excite the host immune system. The preponderance of these live bacterial vaccine vectors is that they can stimulate durable humoral and cellular immunity. Moreover, delivery strategies of heterologous antigen in live bacterial promote the applications of new vaccine development. Genetic technologies are evolving, which potentiate the developing of heterologous antigen delivery systems, including bacterial surface display system, bacterial secretion system and balanced lethal vector system. Although the live bacterial vaccine vector is a powerful adjuvant, certain disadvantages, such as safety risk, must also be taken into account. In this review, we compare the development of representative live bacterial vectors, and summarize the main characterizations of the various delivery strategies of heterologous antigen in live vector vaccines. Published by Elsevier B.V.

Keywords:  Attenuated bacteria; Bacterial secretion system; Bacterial surface display system; Balanced lethal vector system; Live bacterial vaccine vector; Probiotic

Mesh:

Substances:

Year:  2018        PMID: 29550258     DOI: 10.1016/j.imlet.2018.03.006

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  11 in total

1.  Construction of a Lactobacillus plantarum Strain Expressing the Capsid Protein of Porcine Circovirus Type 2d (PCV2d) as an Oral Vaccine.

Authors:  Yi-Han Tseng; Cheng-Chu Hsieh; Tsun-Yung Kuo; Je-Ruei Liu; Ting-Yu Hsu; Shu-Chen Hsieh
Journal:  Indian J Microbiol       Date:  2019-10-23       Impact factor: 2.461

Review 2.  Combined use of lactic-acid-producing bacteria as probiotics and rotavirus vaccine candidates expressing virus-specific proteins.

Authors:  Atefeh Afchangi; Tayebeh Latifi; Somayeh Jalilvand; Sayed Mahdi Marashi; Zabihollah Shoja
Journal:  Arch Virol       Date:  2021-02-03       Impact factor: 2.574

3.  Leishmania tarentolae as an Antigen Delivery Platform: Dendritic Cell Maturation after Infection with a Clone Engineered to Express the SARS-CoV-2 Spike Protein.

Authors:  Ilaria Varotto-Boccazzi; Micaela Garziano; Giulia Maria Cattaneo; Beatrice Bisaglia; Paolo Gabrieli; Mara Biasin; Alessandro Manenti; Diego Rubolini; Mario Clerici; Emanuele Montomoli; Gian Vincenzo Zuccotti; Daria Trabattoni; Sara Epis; Claudio Bandi
Journal:  Vaccines (Basel)       Date:  2022-05-19

Review 4.  Different Methods and Formulations of Drugs and Vaccines for Nasal Administration.

Authors:  Junhu Tai; Munsoo Han; Dabin Lee; Il-Ho Park; Sang Hag Lee; Tae Hoon Kim
Journal:  Pharmaceutics       Date:  2022-05-17       Impact factor: 6.525

Review 5.  Bacteria-Inspired Nanomedicine.

Authors:  Maya Holay; Zhongyuan Guo; Jessica Pihl; Jiyoung Heo; Joon Ho Park; Ronnie H Fang; Liangfang Zhang
Journal:  ACS Appl Bio Mater       Date:  2020-10-08

Review 6.  Mycoplasma pneumoniae Infections: Pathogenesis and Vaccine Development.

Authors:  Zhulin Jiang; Shuihong Li; Cuiming Zhu; Runjie Zhou; Polly H M Leung
Journal:  Pathogens       Date:  2021-01-25

7.  A genetic toolkit and gene switches to limit Mycoplasma growth for biosafety applications.

Authors:  Alicia Broto; Erika Gaspari; Samuel Miravet-Verde; Vitor A P Martins Dos Santos; Mark Isalan
Journal:  Nat Commun       Date:  2022-04-07       Impact factor: 14.919

8.  A SARS-CoV-2 oral vaccine development strategy based on the attenuated Salmonella type III secretion system.

Authors:  Leyang Wu; Lin Li; Xingpeng Yin; Chenyang Li; Wenjie Xin; Lina Liu; Zichun Hua
Journal:  J Appl Microbiol       Date:  2022-07-31       Impact factor: 4.059

9.  Lactococcus lactis expressing sand fly PpSP15 salivary protein confers long-term protection against Leishmania major in BALB/c mice.

Authors:  Elaheh Davarpanah; Negar Seyed; Fariborz Bahrami; Sima Rafati; Reza Safaralizadeh; Tahereh Taheri
Journal:  PLoS Negl Trop Dis       Date:  2020-01-03

10.  Immunogenicity evaluation of recombinant Lactobacillus casei W56 expressing bovine viral diarrhea virus E2 protein in conjunction with cholera toxin B subunit as an adjuvant.

Authors:  Shuo Jia; Xinning Huang; Hua Li; Dianzhong Zheng; Li Wang; Xinyuan Qiao; Yanping Jiang; Wen Cui; Lijie Tang; Yijing Li; Yigang Xu
Journal:  Microb Cell Fact       Date:  2020-10-01       Impact factor: 6.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.